“…Other preclinical studies with retinoblastoma mouse models have used focal therapies, such as EBRT and cryotherapy, and found them to disrupt the blood-ocular barrier, increasing drug delivery [64,118,156]. Ideally, the use of cryotherapy is more attractive than EBRT due to the risks to patients with germline mutations.…”